Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Salter Malcolm
Director at C4 Therapeutics. Filing since 6 Oct 2020.
CIK 0001825124
Company
Date
Role
Action
Shares
Amount
Of holding
CCCC
C4 Therapeutics, Inc.
17 Dec 2021
Director
Sold, plan not stated
755
$22.84K
6.4%
CCCC
C4 Therapeutics, Inc.
19 Nov 2021
Director
Sold, plan not stated
755
$30.28K
6.1%
CCCC
C4 Therapeutics, Inc.
15 Oct 2021
Director
Sold, plan not stated
755
$33.93K
5.7%
CCCC
C4 Therapeutics, Inc.
17 Sep 2021
Director
Sold, plan not stated
755
$37.67K
5.5%
CCCC
C4 Therapeutics, Inc.
20 Aug 2021
Director
Sold, plan not stated
755
$30.75K
5.2%
CCCC
C4 Therapeutics, Inc.
16 Jul 2021
Director
Sold, plan not stated
755
$28.21K
5.0%
CCCC
C4 Therapeutics, Inc.
18 Jun 2021
Director
Sold, plan not stated
755
$28.08K
4.8%
CCCC
C4 Therapeutics, Inc.
21 May 2021
Director
Sold, plan not stated
755
$28.03K
4.6%
CCCC
C4 Therapeutics, Inc.
6 Oct 2020
Director
Bought
1,315
$24.99K
9.0%
9 decisions on file.